Methicillin-resistant Staphylococcus aureus in Nepal

被引：10

作者：

Shrestha, Lok Bahadur ^{[1
,2
]}

Syangtan, Gopiram ^{[3
]}

Basnet, Ajaya ^{[3
]}

Acharya, Krishna Prasad ^{[4
]}

Chand, Arun Bahadur ^{[5
]}

Pokhrel, Khilasa ^{[6
]}

机构：

[1] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia

[2] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia

[3] Tribhuvan Univ, Shi Gan Int Coll Sci & Technol, Kathmandu, Nepal

[4] Anim Quarantine Off, Kathmandu, Nepal

[5] Kist Med Coll & Teaching Hosp, Dept Clin Lab, Kathmandu, Nepal

[6] Kathmandu Med Coll, Dept Microbiol, Kathmandu, Nepal

来源：

JOURNAL OF NEPAL MEDICAL ASSOCIATION | 2021年 / 59卷 / 237期

关键词：

clindamycin; methicillin-resistant Staphylococcus aureus; multi-drug resistance; HEALTH-CARE WORKERS; COAGULASE-NEGATIVE STAPHYLOCOCCI; URINARY-TRACT-INFECTIONS; BIOFILM FORMATION; NASAL COLONIZATION; PREVALENCE; CARRIAGE; ASSOCIATION; THREAT;

D O I：

10.31729/jnma.6251

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Staphylococcus aureus is both a frequent commensal and a leading cause of endocarditis, bacteremia, osteomyelitis and skin and soft tissue infections and device-related infections. We performed this minireview to summarize the prevalence of Staphylococcus aureus among clinical samples and estimate the proportion of methicillin-resistant Staphylococcus aureus. The prevalence of Staphylococcus aureus among clinical isolates in Nepal is 34.5%. On average, the proportion of multi-drug resistance in Staphylococcus aureus is 57.1%. Methicillin-resistant Staphylococcus aureus accounts for a total of 41.7%. Inducible clindamycin resistance was detected in about 35% of the isolates. A regular antimicrobial resistance surveillance mechanism is necessary to mitigate the development of resistance among organisms and further spread of superbugs like methicillinresistance Staphylococcus aureus.

引用

页码：518 / 522

页数：5

共 50 条

[1] Prevalence of methicillin-resistant Staphylococcus aureus in a tertiary hospital in Nepal
Pradhan, P.
Rajbhandari, P.
Nagaraja, S. B.
Shrestha, P.
Grigoryan, R.
Satyanarayana, S.
Davtyan, H.
PUBLIC HEALTH ACTION, 2021, 11 (01): : 46 - 51
[2] Methicillin-resistant Staphylococcus aureus
Turner, Evie
Brownlee, Keith G.
Denton, Miles
JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (02) : 184 - 185
[3] Methicillin-resistant Staphylococcus aureus
Lee, Andie S.
de Lencastre, Herminia
Garau, Javier
Kluytmans, Jan
Malhotra-Kumar, Surbhi
Peschel, Andreas
Harbarth, Stephan
NATURE REVIEWS DISEASE PRIMERS, 2018, 4
[4] Methicillin-resistant Staphylococcus aureus
Losa, JE
Barba, R
Delgado-Iribarren, A
MEDICINA CLINICA, 2002, 119 (19): : 755 - 756
[5] Methicillin-resistant staphylococcus aureus
Ellie J. C. Goldstein
Current Infectious Disease Reports, 2000, 2 (5) : 431 - 432
[6] Methicillin-resistant Staphylococcus aureus
Gosbell, IB
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2004, 5 (04) : 239 - 259
[7] Methicillin-resistant Staphylococcus aureus
不详
Nature Reviews Disease Primers, 4 (1) : 18034
[8] Methicillin-resistant Staphylococcus aureus
Leung, D
AGE AND AGEING, 1998, 27 (03) : 409 - 409
[9] Methicillin-resistant Staphylococcus aureus
Lubowitz, James H.
Poehling, Gary G.
ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2008, 24 (05): : 497 - 499
[10] Methicillin-resistant Staphylococcus aureus
Andie S. Lee
Hermínia de Lencastre
Javier Garau
Jan Kluytmans
Surbhi Malhotra-Kumar
Andreas Peschel
Stephan Harbarth
Nature Reviews Disease Primers, 4

← 1 2 3 4 5 →